Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 30.06
-1.07 (-3.44%)
Apr 21, 2026, 3:00 PM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 6.17 billion as of April 21, 2026. Its market cap has increased by 34.24% in one year.
Market Cap
6.17B
Enterprise Value
6.95B
Revenue
1.54B
Ranking
n/a
PE Ratio
38.43
Stock Price
30.06
Market Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 6.17B, a decrease of -24.32%. That is a compound annual growth rate of -5.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 6.17B | -1.71% |
| Dec 31, 2025 | 6.27B | 45.13% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anhui Huaheng Biotechnology | 7.00B |
| Xiangxue Pharmaceutical | 6.83B |
| Beijing Scitop Bio-tech | 6.71B |
| R&G PharmaStudies | 6.50B |
| Lifecome Biochemistry | 6.31B |
| Shenzhen Weiguang Biological Products | 6.21B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.14B |
| Beijing Konruns Pharmaceutical | 6.14B |